According to the Health Product InfoWatch December 2022 edition released by Health Canada on December 22, 2022, cases of Valtrex-associated DRESS have been reported as a Valtrex side effect. Further, therein, it is reported that GlaxoSmithKline Inc. has updated the Canadian product monograph for Valtrex to add information about the risk of … [Read more...]
Preoperative immunotherapy for mesothelioma shows favorable outcomes
In a study published recently in the journal Clinical Cancer Research, researchers at Baylor College of Medicine found that treating patients who have resectable malignant pleural mesothelioma, meaning that their tumor can be removed with surgery, with immunotherapy [ with immune checkpoint inhibitors ] ahead of surgery resulted in favorable … [Read more...]
Benzene Facts: Learn About the Use of This Toxic Chemical, as well as the Science, Medical, and Legal Aspects
This Benzene Facts page provides some basic information about the use of benzene, a common but toxic chemical, as well as the scientific, medical, and legal aspects of benzene exposure. As such, this Benzene Facts information may be especially helpful to workers diagnosed with leukemia cancer or a blood disease that might be related to their … [Read more...]
Tepezza Medical Articles About Drug Side Effects Focus on Hearing Issues
We are investigating possible Tepezza drug injury cases where the patient, while using Tepezza, started to experience hearing loss or other hearing problems. Specifically, those Tepezza hearing issues include: Hearing loss, ranging from impairment to deafness (Hypoacusis and Sensorineural Hearing Loss) Sound or noise sensitivity that makes … [Read more...]
Asbestos — two to three times more deadly than known
“Clouds of dust were falling on us at every blow of the truncheon, but at that time we knew nothing about asbestos,” recalled Jesús Ropero Calcerrada, a 73-year-old man who was tasked with scraping asbestos from railway carriages during his working life in Beasáin, in the Basque country in Spain. He and others were not offered any protection from … [Read more...]
Tepezza Hearing Loss, Other Tepezza Hearing Problems May be Irreversible and Permanent
Tepezza hearing loss and other Tepezza hearing problems have been reported by medical doctors and patients since this treatment for Thyroid Eye Disease was approved by the FDA in 2020. Those Tepezza hearing problems have involved various medical diagnosis types, including: Hypoacusis: hearing loss ranging from impairment to … [Read more...]
They inhaled asbestos for decades on the job. Now, workers break their silence
Henry Saenz remembers when he first learned what even the tiniest bit of asbestos could do to his body. He was working at a chemical plant where employees used [ asbestos for chlorine production ], and his coworkers warned him about what could happen each time he took a breath: Tiny fibers, invisible to the eye, could enter his nose and mouth and … [Read more...]
FDA AdComm: Copiktra Risk-Benefit Profile No Longer Favorable as a Third-Line CLL/SLL Treatment
The FDA’s Oncologic Drugs Advisory Committee (ODAC) has voted 8-4 against the Copiktra risk-benefit profile, as reported in this September 23, 2022, Endpoint News article, “FDA adcomm takes down Secura Bio’s leukemia drug after final trial results show potential OS detriment”. From that recent news report about the safety of Copiktra … [Read more...]
Malignant Mesothelioma Mortality in Women — United States, 1999–2020
Inhalation of asbestos fibers can cause malignant mesothelioma, a rapidly progressing and lethal cancer of the mesothelium, the thin layer of tissues surrounding internal organs in the chest and abdomen. Patients with malignant mesothelioma have a poor prognosis, with a median survival of 1 year from diagnosis. The estimated median interval from … [Read more...]
Pembrolizumab / Lenvatinib Combo Shows Positive Clinical Activity in Recurrent Pleural Mesothelioma
The combination of pembrolizumab (Keytruda), and lenvatinib (Lenvima) demonstrated promising clinical activity with no unexpected toxicities in patients with malignant pleural mesothelioma (MPM), according to results from the PEMMELA study (NCT04287829) presented at the International Association for the Study of Lung Cancer 2022 World … [Read more...]
- « Previous Page
- 1
- …
- 7
- 8
- 9
- 10
- 11
- …
- 21
- Next Page »